


Scientific review and legislative reform after the pandemic.
Dear citizens – the Corona pandemic has confronted our society with unprecedented challenges and left marks that will accompany us for a long time. A dedicated team is critically examining this topic, shedding light on both the measures taken and their long-term effects.
We invite you to a panel discussion where renowned experts from medicine, politics, pharmaceuticals, and science will exchange well-founded pro and con arguments. The goal is to foster a deeper understanding of the complex interrelations of the crisis through factual discourse and provide guidance for the future.
Background: The revision of the Epidemics Act (EpG) is currently (as of 2025/2026) under parliamentary consultation – it aims to close the gaps identified during the pandemic, particularly in the situation model and digital surveillance. Implementation is targeted for 2028.
A five-minute preview of the Covid Connect panel discussion.
Additional video contributions on the congress's subject matter.
Further shared video clips on the topic.
Note: The video clips shared above come from publicly accessible third-party social media channels and were passed on to us by participants. They reflect solely the opinion of their respective creators, were neither produced nor editorially reviewed by us. We accept no responsibility for their content or accuracy.
Nine contributions examine the medical, legal and social consequences of the pandemic.









Each day: welcome, five expert keynotes and an open discussion.
The programme is being finalised. Speakers and keynote titles will be added progressively.
Doctors, scientists, jurists and politicians from Switzerland and abroad.

































Roster being finalised – more experts will be added.
A concise overview of the key milestones.
After the first cases at the end of 2019, the first case in Ticino was confirmed on February 25, 2020. The Federal Council declared a "state of emergency" in March and closed schools, shops, and restaurants. Switzerland opted out of a total lockdown but prohibited gatherings of more than five people. On December 19, 2020, Swissmedic granted the first regular approval worldwide for the Pfizer/BioNTech vaccine.
The year began with closures until the end of February. The vaccination campaign was significantly expanded (vaccination rate by August around 52%). From September 13, 2021, the certificate requirement (3G) applied to indoor spaces, and in December it was tightened to 2G, with the reintroduction of the home office requirement.
Omicron led to record case numbers, but the situation in hospitals remained manageable. Almost all measures were lifted on February 17, 2022, and the "normal situation" was reinstated from April 1, 2022. By the end of 2022, 19,365 people in Switzerland had died in connection with Covid-19.
Secure your place at the Corona Congress 2026 and stay up to date on the programme and speakers.